South Africa
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -1.71 M
|
June 30, 2024 | USD 0.04 | 1.93% |
|
South Africa |
|
2 |
USD -44.58 M
|
June 30, 2024 | USD 3.52 | 1.00% |
|
South Africa |
|
3 |
USD -1.13 B
|
Sept. 30, 2024 | USD 0.82 | -1.03% |
|
South Africa |
The Biotechnology company in South Africa with the highest Net Cash Used Provided By Financing Activities is Ascendis Health Limited (Johannesburg Stock Exchange: ASC.JO) at USD -1.71 M.
The Biotechnology company in South Africa with the lowest Net Cash Used Provided By Financing Activities is Life Healthcare Group Holdings Limited (Johannesburg Stock Exchange: LHC.JO) at USD -1.13 B.
The top 10 Biotechnology companies in South Africa by Net Cash Used Provided By Financing Activities are Ascendis Health Limited, Adcock Ingram Holdings Limited and Life Healthcare Group Holdings Limited.
The bottom 10 Biotechnology companies in South Africa by Net Cash Used Provided By Financing Activities are Life Healthcare Group Holdings Limited, Adcock Ingram Holdings Limited and Ascendis Health Limited.